Simulating biologically plausible complex survival data

Simulation studies are conducted to assess the performance of current and novel statistical models in pre‐defined scenarios. It is often desirable that chosen simulation scenarios accurately reflect a biologically plausible underlying distribution. This is particularly important in the framework of survival analysis, where simulated distributions are chosen for both the event time and the censoring time. This paper develops methods for using complex distributions when generating survival times to assess methods in practice. We describe a general algorithm involving numerical integration and root‐finding techniques to generate survival times from a variety of complex parametric distributions, incorporating any combination of time‐dependent effects, time‐varying covariates, delayed entry, random effects and covariates measured with error. User‐friendly Stata software is provided. Copyright © 2013 John Wiley & Sons, Ltd.

• Publication year

  2013

• Venue

  Statistics in Medicine

• Publication date

  2013-10-15

• Fields of study

  Biology, Mathematics, Computer Science, Medicine

• Identifiers
  DOI 10.1002/sim.5823PMID 23613458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SURVSIM: Stata module to simulate complex survival data

  2013cited by this paper
• Flexible parametric joint modelling of longitudinal and survival data

  2012cited by this paper
• Generating survival times to simulate Cox proportional hazards models with time-varying covariates

  2012influential reference
• Use of relative and absolute effect measures in reporting health inequalities: structured review

  2012cited by this paper
• Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models

  2012cited by this paper
• Tools to Simulate Realistic Censored Survival-Time Distributions

  2012cited by this paper
• Simulating Complex Survival Data

  2012influential reference
• Quantifying differences in breast cancer survival between England and Norway.

  2011cited by this paper
• Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model

  2011cited by this paper
• Breast cancer adjuvant therapy: time to consider its time-dependent effects.

  2011cited by this paper
• Estimating the cure fraction in population‐based cancer studies by using finite mixture models

  2010cited by this paper
• Flexible modeling of competing risks in survival analysis

  2010cited by this paper
• Further Development of Flexible Parametric Models for Survival Analysis

  2009cited by this paper
• Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

  2009cited by this paper
• Simulating competing risks data in survival analysis

  2009cited by this paper
• Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

  2009cited by this paper
• Comparison of algorithms to generate event times conditional on time‐dependent covariates

  2008cited by this paper
• Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables

  2008cited by this paper
• Estimating survival in newly diagnosed cancer patients: Use of computer simulations to evaluate performances of different approaches in a wide range of scenarios

  2008cited by this paper
• The design of simulation studies in medical statistics

  2006cited by this paper
• Generating survival times to simulate Cox proportional hazards models

  2005influential reference
• Sensitivity analysis for informative censoring in parametric survival models.

  2005cited by this paper
• MOREMATA: Stata module (Mata) to provide various functions

  2005cited by this paper
• Choice of time‐scale in Cox's model analysis of epidemiologic cohort data: a simulation study

  2004cited by this paper
• Introduction to numerical analysis

  2004cited by this paper
• Marginal and hazard ratio specific random data generation: Applications to semi-parametric bootstrapping

  2002cited by this paper
• Introduction to Numerical Analysis

  2001cited by this paper
• Statistical Models Based on Counting Processes.

  1996cited by this paper
• Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group.

  1994cited by this paper
• Primary biliary cirrhosis: Prediction of short‐term survival based on repeated patient visits

  1994cited by this paper
• On the role of finite mixture models in survival analysis

  1994cited by this paper
• Technical Note - Variate Generation for Accelerated Life and Proportional Hazards Models

  1987cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Functional Decomposition and Shapley Interactions for Interpreting Survival Models

  2026cites this paper
• The impact of violation of the proportional hazards assumption on the discrimination of the Cox proportional hazards model

  2026cites this paper
• A Bayesian Multilevel Joint Modeling of Longitudinal and Survival Outcomes in Cluster Randomized Controlled Trial Studies

  2026cites this paper
• Restricted mean survival time in cluster randomized trials with a small number of clusters: Improving variance estimation of the intervention effect from the pseudo-values regression.

  2026cites this paper
• Prediction Intervals for Interim Events in Randomized Clinical Trials with Time-to-Event Endpoints

  2026cites this paper
• The Win Ratio at the Design Stage of Clinical Trials

  2025cites this paper
• The Impact of Violation of the Proportional Hazards Assumption on the Calibration of the Cox Proportional Hazards Model

  2025cites this paper
• AI-driven predictive biomarker discovery with contrastive learning to improve clinical trial outcomes.

  2025cites this paper
• A Spline‐Based Approach to Smoothly Constrain Hazard Ratios With a View to Apply Treatment Effect Waning

  2025cites this paper
• Joint modeling of longitudinal HRQoL data accounting for the risk of competing dropouts

  2025cites this paper
• Adjusting for switches to multiple treatments: Should switches be handled separately or combined?

  2025cites this paper
• A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting

  2025cites this paper
• A decomposition of Fisher’s information to inform sample size for developing or updating fair and precise clinical prediction models — part 2: time-to-event outcomes

  2025influential citation
• Dynamic Prediction of Analysis Timing in Clinical Trials Using Joint Models of Longitudinal and Time‐to‐Event Data

  2025cites this paper
• The Stata Journal Editors’ Prize 2025: Michael J. Crowther

  2025cites this paper
• Permutation Tests Based on the Copula-Graphic Estimator and Their Use for Survival Tree Construction

  2025cites this paper
• Competing risk multistate censored data modeling by propensity score matching method

  2024cites this paper
• Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies

  2024cites this paper
• Multiplicative versus additive modelling of causal effects using instrumental variables for survival outcomes – a comparison

  2024cites this paper
• A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment

  2024cites this paper
• Assessing Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Simulation Study

  2024cites this paper
• Joint modelling of longitudinal ordinal and multi-state data

  2024cites this paper
• Flexible joint model for time-to-event and non-Gaussian longitudinal outcomes

  2024cites this paper
• Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling

  2024cites this paper
• Interpretable Machine Learning for Survival Analysis

  2024cites this paper
• AI-based predictive biomarker discovery via contrastive learning retrospectively improves clinical trial outcome

  2024cites this paper
• Restricted mean survival time to estimate an intervention effect in a cluster randomized trial

  2023cites this paper
• Perils of randomised controlled trial survival extrapolation assuming treatment effect waning: why the distinction between marginal and conditional estimates matters.

  2023cites this paper
• Flexible joint models for multivariate longitudinal and time-to-event data using multivariate functional principal components

  2023cites this paper
• Sample size and predictive performance of machine learning methods with survival data: A simulation study

  2023cites this paper
• Regularized parametric survival modeling to improve risk prediction models

  2023cites this paper
• Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets.

  2023cites this paper
• Simulating survival data when one subgroup lacks information

  2023cites this paper
• Wavelet Support Vector Censored Regression

  2023cites this paper
• The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study

  2023influential citation
• Une comparaison des algorithmes d'apprentissage pour la survie avec données manquantes

  2023cites this paper
• When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials

  2023influential citation
• Using the Lambert Function to Estimate Shared Frailty Models with a Normally Distributed Random Intercept

  2022cites this paper
• On the role of benchmarking data sets and simulations in method comparison studies

  2022cites this paper
• Generating high-fidelity synthetic time-to-event datasets to improve data transparency and accessibility

  2022cites this paper
• Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence

  2022cites this paper
• Simulating time-to-event data subject to competing risks and clustering: A review and synthesis

  2022cites this paper
• Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study

  2022cites this paper
• Examining evidence of time-dependent treatment effects: an illustration using regression methods

  2022cites this paper
• Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer

  2022cites this paper
• Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission

  2022cites this paper
• SurvSHAP(t): Time-dependent explanations of machine learning survival models

  2022cites this paper
• Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays

  2021cites this paper
• Characterization of direct and/or indirect genetic associations for multiple traits in longitudinal studies of disease progression

  2021cites this paper
• Assessing vaccine durability in randomized trials following placebo crossover

  2021cites this paper
• Simulating Survival Data Using the simsurv R Package

  2021influential citation
• Assessing and relaxing the Markov assumption in the illness-death model

  2021cites this paper
• CDSM - Casual Inference using Deep Bayesian Dynamic Survival Models

  2021cites this paper
• Relaxing the assumption of constant transition rates in a multi-state model in hospital epidemiology

  2021influential citation
• The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study.

  2021cites this paper
• Improving Data Transparency and Accessibility in the Research Community through the Construction of Accurately Simulated Time-to-Event Datasets

  2021cites this paper
• Causal inference for observational longitudinal studies using deep survival models

  2021cites this paper
• Minimum sample size calculations for external validation of a clinical prediction model with a time‐to‐event outcome

  2021cites this paper
• Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials

  2021cites this paper
• Combining chains of Bayesian models with Markov melding

  2021cites this paper
• Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma.

  2021cites this paper
• Simulating time-to-event data from parametric distributions, custom distributions, competing-risks models, and general multistate models

  2021cites this paper
• Using median survival in meta-analysis of experimental time-to-event data

  2021cites this paper
• Inverse probability weighting and doubly robust standardization in the relative survival framework

  2021cites this paper
• Bayesian regularization for flexible baseline hazard functions in Cox survival models

  2020cites this paper
• Generalized parametric cure models for relative survival

  2020cites this paper
• A Bayesian inference for the penalized spline joint models of longitudinal and time-to-event data: A prior sensitivity analysis

  2020cites this paper
• Comparison of propensity score methods for pre-specified subgroup analysis with survival data

  2020cites this paper
• Generating Survival Times Using Cox Proportional Hazards Models with Cyclic and Piecewise Time-Varying Covariates

  2020cites this paper
• The effects of misspecification of submodels in joint modeling of repeated measures and time-to-event outcomes

  2020cites this paper
• Generalized Link-Based Additive Survival Models with Informative Censoring

  2020cites this paper
• Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding

  2020cites this paper
• Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study

  2020cites this paper
• A joint modeling approach for longitudinal microbiome data improves ability to detect microbiome associations with disease

  2020cites this paper
• A Two-Stage Approach for Bayesian Joint Models of Longitudinal and Survival Data: Correcting Bias with Informative Prior

  2020cites this paper
• The Importance of the Change Point Recognition in the Landmark Analysis of Immuno-oncology Clinical Trial with the Delayed Treatment Effect

  2020cites this paper
• A flexible parametric accelerated failure time model and the extension to time-dependent acceleration factors

  2020cites this paper
• A Comparison of Cox and Joint Models for Time-to-Event Data

  2019cites this paper
• Copula Link-Based Additive Models for Right-Censored Event Time Data

  2019cites this paper
• Bootstrapping complex time‐to‐event data without individual patient data, with a view toward time‐dependent exposures

  2019cites this paper
• Generating survival times with time-varying covariates using the Lambert W Function

  2019cites this paper
• Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study

  2019cites this paper
• Using dynamic path analysis to estimate a mediation effect through a survival variable

  2019influential citation
• How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies

  2019cites this paper
• Performance of methods to conduct mediation analysis with time‐to‐event outcomes

  2019cites this paper
• Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice

  2019cites this paper
• Joint modeling of progression‐free and overall survival and computation of correlation measures

  2019cites this paper
• Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring

  2019cites this paper
• Fractional polynomial and restricted cubic spline models as alternatives to categorising continuous data: applications in medicine

  2019cites this paper
• Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study

  2019influential citation
• Comparison of model-building strategies for excess hazard regression models in the context of cancer epidemiology

  2019cites this paper
• Joint modelling of progression-free and overall survival and computation of correlation measures

  2018cites this paper
• A new generalization of the gamma distribution with application to negatively skewed survival data

  2018cites this paper
• Flexible and structured survival model for a simultaneous estimation of non-linear and non-proportional effects and complex interactions between continuous variables: Performance of this multidimensional penalized spline approach in net survival trend analysis

  2018cites this paper
• Flexible parametric models for cancer patient survival : loss in expectation of life and further developments

  2018cites this paper
• Spatial Analysis of Cluster Randomised Trials

  2018cites this paper
• Joint longitudinal and time-to-event models for multilevel hierarchical data

  2018cites this paper
• Statistical methods to analyse registry data in a comparative setting

  2018cites this paper
• Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study

  2018cites this paper
• Parametric and penalized generalized survival models

  2018cites this paper